유럽 ​​Point-Of-Care 진단 시장 - 2029년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 유럽 Point-Of-Care 진단 시장

진료 시점 진단 시장은 2022년에서 2029년의 예측 기간 동안 10.22%의 시장 성장을 목격할 것으로 예상됩니다. 진료 시점 진단 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 표적 질병의 발생률 증가는 진료 시점 진단 시장의 성장을 가속화하고 있습니다.

Point-Of-Care 진단은 감염을 일찍 그리고 빠르게 식별하는 데 사용되는 접근 방식입니다 . 이러한 절차는 매우 민감하고 비용 효율적이며 짧은 시간 내에 결과를 생성합니다. 이러한 테스트 방법은 학교, 의사, 외래 환자, 임상 실험실 및 가정 건강 관리 에서 사용됩니다 .

예측 기간 동안 진료 시점 진단 시장 성장을 촉진할 것으로 예상되는 주요 요인은 가정 의료 에 대한 필요성 증가로 제조업체가 성장했습니다. 나아가 환경 모니터링 및 공중 보건에서 진료 시점 진단의 중요성이 커지면서 진료 시점 진단 시장 성장이 더욱 촉진될 것으로 예상됩니다. 더욱이 기술 개발과 신제품 출시로 진료 시점 진단 시장 성장이 완화될 것으로 예상됩니다. 반면, 상환 삭감과 예산 제한으로 인한 비용 압박은 타임라인 기간 동안 진료 시점 진단 시장 성장을 더욱 방해할 것으로 예상됩니다.

또한, 현대 면역 검사 기술 에 대한 규제 승인의 증가는 향후 몇 년 동안 진료 시점 진단 시장의 성장에 대한 잠재적 기회를 더욱 제공할 것입니다. 그러나 시간이 많이 걸리는 계약 정책은 제품 출시를 위한 개발 기간을 상당히 늘려 가까운 미래에 진료 시점 진단 시장의 성장에 더욱 도전이 될 수 있습니다.

This point-of-care diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the point-of-care diagnostics market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth. 

Europe Point-Of-Care Diagnostics Market Scope and Market Size

The point-of-care diagnostics market is segmented on the basis of product, platform, prescription and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications. 

• On the basis of product, the point-of-care diagnostics market is segmented into glucose monitoring products, cardio metabolic, infectious disease, coagulation, pregnancy and fertility, tumor or cancer marker, urinalysis, cholesterol, haematology, drugs-of-abuse, fecal occult and others. Glucose monitoring products is further sub segmented into strips, meters and lancets and lancing device. Cardiometabolic is further sub segmented into cardiac marker, blood gas or electrolytes and HBA1C. Infectious disease is further sub segmented into influenza, HIV, hepatitis C, sexually transmitted disease (STD), healthcare-associated infection (HAI), respiratory infection, tropical disease and other infectious disease. Coagulation is further sub segmented into PT or INR and activated clotting time (ACT or APTT). Pregnancy and fertility is further sub segmented into pregnancy test and fertility test.
• On the basis of platform, the point-of-care diagnostics market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics and immunoassays.
• On the basis of prescription, the point-of-care diagnostics market is segmented into prescription-based testing and OTC testing.
• On the basis of end user, the point-of-care diagnostics market is segmented into clinical laboratories, outpatient healthcare and ambulatory care settings, hospitals or critical care centers, home care, research laboratories and other.

Point-Of-Care Diagnostics Market Country Level Analysis

The point-of-care diagnostics market is analysed, and market size insights and trends are provided by country, product, platform, prescription and end user as referenced above.      

The countries covered in the point-of-care diagnostics market report are the Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

France is projected to observe significant amount of growth in the point-of-care diagnostics market due to the rise in the prevalence of unhealthy lifestyles and growing number of chronic diseases. Moreover, the augmented FDA approvals and government laws that are connected to healthcare advancement which is further anticipated to propel the growth of the point-of-care diagnostics market in the region in the coming years.

The country section of the point-of-care diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites, and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The point-of-care diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the point-of-care diagnostics market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the point-of-care diagnostics market. The data is available for the historic period 2010-2020.

Competitive Landscape and Point-Of-Care Diagnostics Market Share Analysis

The North America point-of-care diagnostics market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the point-of-care diagnostics market.

Point-of-Care 진단 시장 보고서에서 다루는 주요 기업으로는 Abbott, Danaher, BD, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Instrumentation Laboratory SpA – Werfen, bioMérieux SA, Trividia Health, Inc., QIAGEN, Sekisui Diagnostics, Siemens Healthcare GmbH, Quidel Corporation, Spectral Medical Inc., Abaxis, Nova Biomedical, Trinity Biotech, Alfa Scientific Designs, Inc., ?PTS Diagnostics, Bio-Rad Laboratories, Inc., Medica Corporation 등이 있습니다.

SKU-1906